The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> MEDICINE >> NEWS
FDA approves Wellbutrin XL(TM)

patients and one six-week controlled trial of outpatients who met criteria for major depression. The efficacy of bupropion in maintaining an antidepressant response for up to 44 weeks was established with the sustained-release formulation in a placebo-controlled trial. Bupropion has also been shown to be effective in preventing relapse of depression. In other clinical studies, the active ingredient in Wellbutrin XL has proven comparable to Zoloft* in treating moderate to severe recurrent major depression.

SAFETY INFORMATION

Wellbutrin XL has been proven bioequivalent to both Wellbutrin Tablets and Wellbutrin SR tablets. Given that there are multiple formulations of bupropion, familiarity with the different names and dosing schedules is important to avoid dosing errors.

Placebo-controlled trials of Wellbutrin SR show it to be generally well tolerated. Adverse events reported in at least 10 percent of patients treated with Wellbutrin SR 300 mg/day or 400 mg/day and at a rate at least twice that of placebo were dry mouth, nausea, insomnia, dizziness, weight loss, and pharyngitis. Similar adverse events would be expected with Wellbutrin XL.

Wellbutrin XL is contraindicated in patients who have or have had a seizure disorder, patients being treated with Zyban (bupropion hydrochloride) Sustained-Release Tablets or Wellbutrin SR or any other medications that contain bupropion, patients who have or had bulimia or anorexia nervosa, patients undergoing abrupt discontinuation of alcohol or sedatives (including benzodiazepines), and patients taking monoamine oxidase (MAO) inhibitors.

In treating depression, physicians should be aware that Wellbutrin XL is associated with a risk of seizures which is dose-related. While Wellbutrin XL has not been formally evaluated in clinical trials, its incidence of seizure may be similar to that of the immediate-release and the sustained-release formulations of bupropion, since it has demonst
'"/>

Contact: Holly Russell
919-483-2839
Cooney Waters Group, Inc.
29-Aug-2003


Page: 1 2 3 4

Related medicine news :

1. FDA approves Pfizers Lyrica for the treatment of the two most common forms of neuropathic pain
2. FDA approves Enablex for treatment of overactive bladder
3. FDA approves Fosrenol(R) in end-stage renal disease (ESRD) patients
4. FDA approves Adderall XR (R) to treat ADHD in adults
5. FDA approves EPZICOM
6. FDA approves new labelling for Seroquel in bioplar mania
7. FDA approves Enbrel to treat psoriasis
8. FDA approves Climara Pro to treat menopause symptoms
9. FDA approves new approach to schizophrenia treatment
10. FDA approves new HIV protease inhibitor, Lexiva (TM)
11. FDA approves Baxters ADVATE for the treatment of hemophilia A

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: FDA approves Wellbutrin

(Date:11/23/2009)...wswire-USNewswire/--TheAmericanSocietyofHematology...ducation,andmediacompany,arelaunching"ExploretheMy...parkinterestinthefieldsofscienceandmedicine,inaddi...sinhematology. ,, "Manyhematologistsmayremember...nt,whichmadelearningaboutbloodreallyfun,"statedNan...
(Date:11/23/2009)...hildren who don,t access health care from the same...antly more likely to have unmet health care needs ...ublished in the journal Pediatrics . , Studies...and delivery of quality health care for children, ...y debates about health insurance reform, much of t...
(Date:11/23/2009)...p by 63 percent with moderate-to-high intensity wo...ws) -- Moderate-to-high intensity exercise such as...e risk in older men but not in women, researchers ...nd women, average age 69, in Manhattan who were fo...re were 238 strokes among the participants. At the...
(Date:11/23/2009)...an to head the agency, said lives could be at risk... The fallout from last week,s controversial recomm...mogram testing for breast cancer continues, with a...alth advising women to ignore the guidelines. ,...unequivocally this will increase the number of wom...
(Date:11/23/2009)...3/PRNewswire/--Hazelden,theinternationallyrenowned...eleadershipteamforitsnewrecoverycenterinNaples,Flo...openinlateMarch2010,andwillinitiallyprovideaddicti...familyandoutpatientservices. ,, MichaelDemask,P...ityinNaples,withBrendaIliff,M.A.,L.A.D.C.,asclinic...
Breaking Medicine News(10 mins):Health News:New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 2Health News:New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 3Health News:Children who lack continuity with a regular health care provider miss needed services 2Health News:Children who lack continuity with a regular health care provider miss needed services 3Health News:Vigorous Exercise Cuts Stroke Risk for Men, Not Women 2Health News:Women Should Ignore New Mammogram Guideline, Ex-NIH Chief Says 2Health News:Women Should Ignore New Mammogram Guideline, Ex-NIH Chief Says 3Health News:Hazelden Names Leadership Team for New Recovery Center in Naples, Florida 2
(Date:11/23/2009)...3/PRNewswire/--Reportlinker.comannouncesthatanewma... TheFutureoftheDiagnosticImagingMarketto2015 ,...re-of-the-Diagnostic-Imaging-Market-to-2015.html#u...paign=prnewswire ,, Description ,, The...mmary ,, GlobalMarketsDirect,s"TheFutureoftheD...
(Date:11/23/2009)...3/PRNewswire/--Reportlinker.comannouncesthatanewma... U.S.MarketforPACSandEMR ,, http://www.repo...tml#utm_source=prnewswire&utm_medium=pr&ut...rPACSwasvaluedatalmost$1.3billion,representinganin...pitals(500+beds),mediumhospitals(201-499beds),comm...
(Date:11/23/2009)...ON,Nov.23/PRNewswire-FirstCall/--AMICAS,Inc.(Nasda...lutions,todayannouncedthatitwillhighlightitsenterp...lSocietyofNorthAmerica(RSNA)annualmeetingfromNovem...hHallinbooth#7124. ,, (Logo: http://www.newscom...enthenationalconversationabouthealthcarereform,the...
Breaking Medicine Technology:Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 2Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 3Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 4Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 5Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 6Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 7Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 8Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 9Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 10Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 11Reportlinker Adds U.S. Market for PACS and EMR 2Reportlinker Adds U.S. Market for PACS and EMR 3Reportlinker Adds U.S. Market for PACS and EMR 4Reportlinker Adds U.S. Market for PACS and EMR 5Reportlinker Adds U.S. Market for PACS and EMR 6Reportlinker Adds U.S. Market for PACS and EMR 7Reportlinker Adds U.S. Market for PACS and EMR 8Reportlinker Adds U.S. Market for PACS and EMR 9Reportlinker Adds U.S. Market for PACS and EMR 10Reportlinker Adds U.S. Market for PACS and EMR 11Reportlinker Adds U.S. Market for PACS and EMR 12Reportlinker Adds U.S. Market for PACS and EMR 13AMICAS' Enterprise Imaging Solutions Highlighted at RSNA 2009 2AMICAS' Enterprise Imaging Solutions Highlighted at RSNA 2009 3Los Angeles DUI Attorney Claims Diabetics Often Falsely Convicted of Drunk Driving 57756 1Los Angeles DUI Attorney Claims Diabetics Often Falsely Convicted of Drunk Driving 57756 2Frost 26 Sullivan 3A Key Therapeutic Areas to Remain Strongest Drivers of CRO Revenue Growth in the United States 57752 1Frost 26 Sullivan 3A Key Therapeutic Areas to Remain Strongest Drivers of CRO Revenue Growth in the United States 57752 2Frost 26 Sullivan 3A Key Therapeutic Areas to Remain Strongest Drivers of CRO Revenue Growth in the United States 57752 3Volcano Corporation Announces Schedule of Events for the 2009 Transcatheter Cardiovascular Therapeutics 28TCT 29 Conference 14174 1Volcano Corporation Announces Schedule of Events for the 2009 Transcatheter Cardiovascular Therapeutics 28TCT 29 Conference 14174 2Volcano Corporation Announces Schedule of Events for the 2009 Transcatheter Cardiovascular Therapeutics 28TCT 29 Conference 14174 3Volcano Corporation Announces Schedule of Events for the 2009 Transcatheter Cardiovascular Therapeutics 28TCT 29 Conference 14174 4Volcano Corporation Announces Schedule of Events for the 2009 Transcatheter Cardiovascular Therapeutics 28TCT 29 Conference 14174 5Volcano Corporation Announces Schedule of Events for the 2009 Transcatheter Cardiovascular Therapeutics 28TCT 29 Conference 14174 6
Other News:
...pitals that lag behind in following treatment guid...e discharge than patients at "leading" hospitals, ...n Heart Association's Scientific Sessions 2002.......hospitals (those with low guideline adherence) to ...
...of its kind, researchers discovered that bone marr...antly enhanced function, according to findings rep...ientific Sessions 2002....Heart wall contraction i... bone marrow injected into scar tissue caused by h...
...en named by Scientific American magazine as one of...rst "celebration of visionaries from the worlds of...mplishments point toward a brighter technological ...ach with two professors selected, were the only un...
...TS CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS....s in patients with chronic obstructive pulmonary d...k and more rapid onset of exacerbations, together ... quality of life. The Dutch researchers studied 2...
health news:Death rates lower in hospitals that follow heart attack guidelines 2health news:Death rates lower in hospitals that follow heart attack guidelines 3health news:Marrow injection gets damaged hearts moving 2health news:Marrow injection gets damaged hearts moving 3health news:UCLA professors James Heath, Gary Small named to Scientific Americans list of 50 visionaries 2health news:American Thoracic Society Journal news tips for November (second issue) 2health news:American Thoracic Society Journal news tips for November (second issue) 3
...he World Health Organization's focus on human reso...WHR) is welcome, the lack of detailed data in the ...is week's issue of The Lancet.......The WHR shares...n April 7. Many countries have critical shortages ...
...cination against severe childhood tuberculosis (TB...as it is a highly cost-effective intervention, acc...et.......BCG vaccination has shown consistently hi...idence on its own is not sufficient to justify BCG...
...e encephalitis might be more widespread in Indones...oday in the open access journal BMC Medicine, rese...cephalitis, a potentially lethal disease caused by... Indonesian island of Bali. The researchers found ...
...ning high blood pressure treatment may reduce the ...in the rapid access issue of Stroke: Journal of th...e study Rita Peila, Ph.D., an epidemiologist at th...ry year of hypertension treatment, there is increa...
health news:Sustained blood pressure treatment lowers dementia risk in elderly 2health news:Sustained blood pressure treatment lowers dementia risk in elderly 3